Table 2.
Secondary triadopathies
Disorder | Gene(s) | Relationship to Triad |
---|---|---|
Myotonic dystrophy type I | DMPK (CTG repeat expansion in 3’UTR) | Abnormal splicing of key triad gene products (RyR1, DHPR, and BIN1), leading to abnormal EC coupling and altered muscle histopathology |
Dystrophinopathies | DMD | Hypernitrosylated RyR1 leading to chronic channel “leakiness” |
Sarcoglycanopathies | SGCA, SGCB, SGCD, and SGCG | Hypernitrosylated RyR1 leading to chronic channel “leakiness” |
Dysferlinopathies | DYSF | Dysferlin is a T-tubule component. May stabilize T-tubule and/or chaperone triad proteins |
Calpainopathies | CAPN3 | Partial localization to the triad. Loss of CAPN3 associated with reduced RyR1 expression |
SEPN1-related myopathies | SEPN1 | Histopathology similar to RYR1-related myopathies. Direct interaction with RyR1 |
CCDC78-associated myopathy | CCDC78 | Partial localization to the triad. Mutation associated with RyR1 accumulation and abnormal triad structure |
UTR = untranslated region; RyR1 = ryanodine receptor; DHPR = dihydropyridine receptor; BIN1 = bridging integrator 1; EC = excitation–contraction; CAPN3 = calpain-3